{"id":"W2039310969","doi":"10.1038/sj.bjc.6600261","title":"Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Capecitabine; Medicine; Metastatic breast cancer; Paclitaxel; Oncology; Internal medicine; Breast cancer; Chemotherapy; Phases of clinical research; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001568342,0.0003204644,0.001221747,0.0001968228,0.0001290756,0.00004439516,0.0001090826,0.00005108311,0.001546953],"category_scores_gemma":[0.00001873585,0.0002253442,0.0001095057,0.0004750997,0.0001864945,0.0004296238,0.00001678829,0.0004235939,9.245576e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003704055,"about_ca_system_score_gemma":0.0002521252,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001297686,"about_ca_topic_score_gemma":0.008644492,"domain_scores_codex":[0.9978592,0.00009955515,0.000712711,0.000299775,0.0005847258,0.0004440354],"domain_scores_gemma":[0.9982397,0.00006811925,0.0006462768,0.0001275555,0.0006387285,0.0002796098],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.62377,0.005822101,0.2680249,0.00007834099,0.001544897,0.001419472,0.0003162973,0.001000698,0.0000673542,6.494677e-7,0.001086729,0.09686862],"study_design_scores_gemma":[0.8659806,0.01171136,0.115807,0.001857022,0.001754329,0.001146311,0.00007670983,0.0002249112,0.0001749696,0.000002948306,0.0009381804,0.000325627],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905558,0.006697145,0.00003564648,0.0005777745,0.0002666469,0.001441392,0.0001809156,0.00001934056,0.0002253153],"genre_scores_gemma":[0.9958383,0.002232751,0.0006497001,0.0002039689,0.0003453565,0.000181179,0.00002553792,0.00005759532,0.0004655629],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2422107,"threshold_uncertainty_score":0.9993657,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02244321630793095,"score_gpt":0.3270490110939391,"score_spread":0.3046057947860081,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}